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We have investigated the effect of sphingomyelin (SM) to ceramide enzymatic conversion on lipid bilayers using Giant Unilamellar Vesicles
(GUVs). Sphingomyelinase was added externally to GUVs containing various proportions of SM. In situ asymmetrical SM conversion to
ceramide reduced the area of one leaflet. In the absence of equilibration of all the lipids between the two leaflets, a mismatch between the two
monolayers was generated. The tension generated by this mismatch was sufficient to trigger the formation of membrane defects and total vesicle
collapse at relatively low percentage of SM (≈5% mol). The formation of nanometric size defects was visualised by AFM in supported bilayers.
Vesicle rupture was prevented in two circumstances: (a) in GUVs containing a mixture of ld and lo domains and (b) in GUVs containing 5% lyso-
phosphatidylcholine. In both cases, the accumulation of enough ceramide (at initial SM concentration of 10%) allowed the formation of ceramide-
rich domains. The coupling between the two asymmetrical monolayers and the condensing effect produced by the newly formed ceramide
generated a tension that could underlie the mechanism through which ceramide formation induces membrane modifications observed during the
late stages of apoptosis.
© 2007 Elsevier B.V. All rights reserved.Keywords: Ceramide; Sphingomyelinase; Membrane surface tension; Lipid flip-flop; Lipid asymmetry; Lipid scrambling1. Introduction
Ceramide is produced in cell membranes from its precursor
sphingomyelin (SM) through the enzymatic activity of
endogenous sphingomyelinase [1–3]. Ceramide function in
the plasma membrane during different cell processes as
apoptosis, senescence, immune response, bacterial pathogenesis
and cell-cycle arrest [4], is supposed to be a second messenger
[5,6]. However, its mode of action is still unclear. It is not
known if its action is exerted through binding to specific
intracellular protein targets or if, on the contrary, it is its strong
impact on membrane structure (microdomain function, mem-
brane vesiculation, fusion, fission and vesicular trafficking) that
plays a role in cellular signalling [7].
The presence of ceramide has important effects on the
physical properties of the membrane. The small size of⁎ Corresponding author. Tel.: +33 1 58 41 51 05; fax: +33 1 58 41 50 24.
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doi:10.1016/j.bbamem.2007.01.001ceramide polar headgroup affects the overall membrane
curvature and stability, possibly by promoting the lamellar–
hexagonal phase transition [8,9], pore formation [10], and
endocytosis stimulation [11–13]. Ceramide also shows a
strong tendency to segregate from other lipids forming
highly ordered ceramide-enriched microdomains. Ceramide
phase diagrams for different PC fluid matrix have been
extensively studied [14–18]. In addition, the presence of SM
and cholesterol augments ceramide partitioning into gel or
liquid ordered domains [15,16,19]. It has been also reported
that ceramide competes with cholesterol in forming ordered
lipid domains [20]. Finally, ceramide, compared with other
lipids, has an unusual characteristic, namely its rapid trans-
membrane diffusion (flip-flop). Bai and Pagano measured a
half-time of 22 min at 37 °C for a fluorescent analogue of
ceramide in lipid vesicles [21] and more recently a half-time
of less than 1 min at 37° was reported for unlabeled-C16
ceramide in giant vesicles and in the erythrocyte plasma mem-
brane [22].
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ceramide to a lipid mixture that is used to form bilayers. An
interesting and complementary approach to study the influence
of ceramide in lipid bilayers is to increase in situ its
concentration through SM enzymatic digestion by SMase
[8,23–28]. This asymmetric increase in ceramide concentration
closely resembles the mechanism of ceramide generation which
takes place in vivo before triggering other cellular responses.
The newly formed ceramides are also capable of inducing
visible membrane transformations: membrane fusion [8,23,24],
vesicle budding [25], and also to facilitate the transbilayer
translocation of other lipids (scrambling), possibly through the
formation of lamellar to inverted hexagonal phase transition in
membranes [26]. Scrambling in apoptosis and ceramide
generation seems to be closely linked [29]. However, not
much attention has been paid to the fact that when the ceramide
content in the membrane is increased due the SMase
hydrolysing activity, physical changes occur besides overall
increase in ceramide concentration due to the very slow
transmembrane diffusion of SM, hence to the very asymmetrical
structure of the bilayer that is formed.
GUVs, with a diameter in the range 10–100 μm i.e. visible
by light microscopy, are useful model systems to investigate
membrane domains [30]. They have allowed the observation of
vesicle deformations by membrane asymmetry [22,31]. Here,
we used GUVs to explore the effect of the lateral stress
generated by the SMase when hydrolysing SM in situ. We have
analysed the effect on relaxed vesicles with an excess area, on
quasi-spherical lipid vesicles in the fluid phase, and in vesicles
where lo–ld domains coexist. The overall morphological
changes suggest that SMase induces a lateral tension caused
both by the asymmetrical SM distribution following SMase
treatment and by the condensing effect of the newly formed
ceramide. Observations on supported bilayers with AFM
confirmed the ceramide production, its segregation in gel
domains after its redistribution membrane and the generation of
small holes in the membrane induced by the lateral tension.
2. Materials and methods
2.1. Chemicals
Egg phosphatidylcholine, brain sphingomyelin, egg phosphatidylethanola-
mine, lyso-phosphatidylcholine, rhodamine phosphatidylethanolamine and
cholesterol were purchased from Avanti-Polar Lipids (USA). Red Texas
phosphatidylethanolamine was acquired from Molecular Probes (USA).
Sphingomyelinase from Bacillus cereus, sucrose, glucose, and all other
chemicals were purchased from Sigma-Aldrich (USA).
2.2. Giant unilamellar vesicles preparation
Giant Unilamellar Vesicles (GUVs) made of EPC, EPC:SM (98:2% mol) or
EPC:EPE:SM:Lyso-PC:cholesterol:RTPE:RhoPE (at different mol ratios, indi-
cated when necessary) were prepared following the electroformation method
[32,33]. The fabrication chamber is composed by two conductor cover slides
coated with a thin transparent film of indium tin oxide and separated by a Teflon
spacer of 0.5 mm. 15 μl of lipid solution in chloroform at 0.25 mg/ml
concentration were deposited on both conducting cover slides. After evapora-
tion, the chamber was placed in vacuum for 1 h to eliminate residual solvent.
The film was re-hydrated with a sucrose solution (200 mosM). The chamber wasrapidly connected to an A.C. power supply, generating a low frequency voltage
(8 Hz) that was progressively increased from 0 to 1.1 V in 40 min. After one
night, the voltage was increased to 1.3 V while decreasing the frequency to 4 Hz
for 1 h in order to detach the vesicles from the cover slides. The vesicles
obtained had a spherical shape. Domains could be seen by fluorescence
microscopy for particular lipid mixtures: EPC:EPE:SM:chol (0:1:2:1), (1:1:1:1),
(1.5:1:0.5:1) molar ratios due to the presence 1% mol fluorescent lipids (RTPE
or RhoPE) in the lipid composition. SM proportion was progressively decreased
(down to 5%) and replaced with EPC. We used EPC, because of EPE does not
form lipid vesicles at high molar ratios. Molar ratios tested were EPC:EPE:SM:
chol (0:1:2:1), (1:1:1:1), (1.5:1:0.5:1), (1.6:1:0.4:1) and (1.8:1:0.2:1). EPC was
substituted in experiments carried out to study Lyso-PC influence. Lipid molar
ratios were EPC:EPE:SM:Chol:Lyso-PC (1.6:1:0.2:1:0.2) and (1.2:1:0.4:1:0.4).
In order to obtain prolate shape vesicles, i.e. to have a large surface to
volume ratio necessary for shape changes, the glucose solution was allowed to
evaporate for more than 1 h at room temperature.
2.3. Supported lipid bilayers preparation
EPC:EPE:SM:Chol (1:1:1:1 mol) Large Unilamellar Vesicles (LUVs) of
200 nm size were fabricated at 1 mg/ml by extrusion in buffer (20 mM HEPES,
150 mM KCl, pH 7.5) at 42 °C. A drop of the LUVs solution was incubated on
freshly cleaved circular pieces of mica glued onto a Teflon surface in presence of
10 mM CaCl2. After several minutes (down to 30 min), the samples were
extensively washed with buffer and used for AFM imaging. AFM images were
taken with an Atomic Force Microscope (Nonatec Electrónica, Madrid, Spain)
operated in the jump mode [34]. The scanning piezo measurement was
calibrated using silicon calibrating gratings. Silicon nitride tips (DI instruments)
with constant force of 0.73–0.38 N/m were used.
2.4. Sphingomyelinase assay in GUVs
A few μl of the solution containing spherical GUVs were transferred with a
micropipette from the fabrication chamber to the observation chamber
containing 500 μl of glucose solution with an osmolarity slightly above 200
mosM. The difference in density between outside and inside mediums permitted
vesicle sedimentation in the observation chamber and provided a better contrast
for light microscopy. Once a vesicle was targeted, 10 μl of 1 unit/ml protein
concentration (in 9 mMCaCl2 and 1.5 mMMgCl2 aqueous solution) was added.
Shape changes induced by sphingomyelin to ceramide transformation were
monitored by observation with a fluorescent optical microscope (inverted
microscope Zeiss IM35 or Nikon Eclipse E600FN) equipped with a CCD
camera (Micro Max 5MHz system Princeton Instruments, Inc. or Nikon DS-L1).
2.5. Sphingomyelinase assay in supported bilayers
As in case of GUVs, once a lipid bilayer region was targeted, up to 30 μl of 1
unit/ml protein concentration (in 9 mM CaCl2 and 1.5 mM MgCl2 aqueous
solution) was added locally while continuously observing the same region.3. Results
3.1. Vesicles with sphingomyelin that lack lipid ordered
domains were unstable upon SMase addition
Incubation with SMase of spherical vesicles containing SM
triggered membrane rupture after a few minutes. The membrane
collapse was observed by optical microscopy even when SM
content in vesicles was low (∼5% mol). Vesicle rupture was
preceded by opening (lasting up to seconds), enabling the
observation of small vesicles efflux, when giant vesicles had
encapsulated smaller vesicles, as shown in Fig. 1. When small
vesicles were outside the giant “mother” vesicle, they became
accessible to SMase and eventually collapsed themselves.
Fig. 1. Transient opening in an EPE:SM:chol (1:2:1) vesicle after addition of SMase. Time after injection: (a) 30 s, (b) 50 s, (c) 1 min, (d) 1 min 30 s, (e) 1 min 45 s, (f)
2 min 5 s. The white arrow points towards a transient opening through which small vesicles efflux from inside to outside. White stars indicate vesicles which undergo
total membrane rupture when in contact with SMase. Scale bar: 10 μm.
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the tension induced by the asymmetric membrane generated by
the enzyme. Several control experiments were carried out with
vesicles formed with EPC, in lack of SM. Alternatively SMase
was added to vesicles containing SM in the absence of Ca2+ and
Mg+2 cations, which are known to be essential for SMase
activity [35]. In both cases vesicles did not undergo any
transformation. If the aqueous solution containing Ca2+ and
Mg+2 was injected in the absence of SMase, no transformation
took place either. Finally, if EDTA (25 mM) was present in the
external medium the enzyme had no activity and the vesicles
did not undergo shape change (not shown).
3.2. Deflated vesicles formed invaginations upon SMase
addition
Spherical vesicles that were deflated by osmotic pressure
took a prolate shape, and possessed a surface excess, which
allowed a smooth relaxation of membrane tension after SMase
addition. When deflated EPC GUVs containing 2% of SM
were incubated with SMase at 20 °C, a prolate-oblate transition
took place usually in the first 5 min and an invagination
appeared 1–2 min later (Fig. 2). We always observed a single
stable invagination at the pole of the giant vesicle. The dark
appearance indicated that the medium inside the invagination
was that of the outer environment (glucose) and not that of the
inner one (sucrose) (see Materials and methods). The
invagination therefore constituted a lighter pocket within the
GUV. This explains why it was always found at the centre and
on the top of the GUV. The presence of an invagination rather
than a budd was confirmed by changing the focus of the
image. The shape change observed was in accordance with
vesicles shape changes theory and indicated a surface
asymmetry, with the inner monolayer area larger than the
outer one [36].3.3. Vesicles containing domains can be used to estimate the
lateral strain induced by SM hydrolysis
Some of the vesicles prepared with lipid composition EPC:
EPE:SM:Chol (X:1:2–X:1 mol) presented coexisting liquid
ordered and liquid disordered phases. If the bilayers equilibra-
tion was allowed, smaller domains of identical composition
coalesced until total phase separation occurred, minimizing the
contact region between phases, and maintaining the membranes
under tension [30] (Fig. 3a). When vesicles were deflated due to
solvent evaporation the initial spherical vesicles adopted an
eight shape with two spherical caps with different radii
connected by an interfacial region. The line tension between
domains precluded their mixing within the GUV. Membranes of
both spherical caps were under lateral tension as revealed by the
absence of membrane undulations.
Subsequent SMase treatment of vesicles containing several
lateral domains induced further shape transformation. The
membrane tension due to SM hydrolysis was relaxed by
adjusting the reduced vesicle surface to volume ratio. The
higher surface tension (Figs. 3b and c) increased the contact area
between different domains. Thus, the interfacial area relaxed the
surface tension and initially prevented membrane rupture. In a
second step, mixing of domains occurred and domain segrega-
tion disappeared (Figs. 3d to f). Afterwards, ceramide rich-
domains were observed, with a domain typology similar to that
observed when lyso-PC was present (see below, Fig. 5c).
Further exposure of these vesicles to enzymatic activity pro-
duced vesicle rupture.
Micrographs observations were used to estimate the area loss
induced by ceramide formation. Taking into account that
fluorescent images represent slices of three-dimensional objects
with spherical symmetry, simple geometrical calculations
allows one to estimate the area decrease associated with a
transition from double budded vesicle to a sphere. We assumed
Fig. 2. Formation of an invagination in an EPC:SM (98:2 mol) vesicle after addition of SMase. Time after injection: (a) 0; (b) 7 min 10 s; (c) 7 min 20 s; (d) 7 min 30 s;
(e) 7 min 40 s; (f) 7 min 50 s; (g) 8 min; (h) 8 min 10 s; (i) 8 min 49 s; (j) 8 min 51 s; (k) 8 min 53 s; (l) 9 min 10 s. Scale bar: 10 μm. See text for more information.
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since no contrast modification was detected with vesicles
observed under bright field illumination. As shown in Fig. 4, the
initial shape corresponded to that of two spherical caps and the
final shape corresponded to a single sphere. R1, R2, h1, h2 and Rf
were measured on micrographs for different vesicles and SM
ratios deduced from the lipid composition (Fig. 4). The
percentage of area reduction is: 100·(Sf−S0) /S0. The measured
area decrease for such transformation was on the order of 10%.
This percentage, which characterises the shape change, was
independent of the initial SM concentration in the lipid mixtureFig. 3. Shape change produced after addition of SMase in an EPE:SM:chol (2.5:0.
injection: (a) 0, (b) 7 min 17 s, (c) 7 min 50 s, (d) 8 min 28 s, (e) 8 min 40 s, (f) 9(see Discussion and Fig. 4). When vesicles reached the
spherical conformation, continuous SM hydrolysis produced
the formation of domains which are likely to be ceramide-
enriched domains. For a SM concentration higher than 12.5%
mol the liposomes rupture occurred (not shown).
3.4. Lyso-PC stabilised membrane integrity and allowed
ceramide rich domains formation
The presence of Lyso-PC in the membrane composition
(see Materials and methods) protected the vesicles from5:1 mol) vesicle containing lipid phase separation (lo+ ld domains). Time after
min. Scale bar: 10 μm.
Fig. 4. Area decrease measurements after addition of SMase to vesicles presenting lipid phase separation (lo+ ld domains). Both areas at initial state and final state are
parameterised by assuming that images which are taken in equatorial plane possess spherical symmetry. h1, h2, R1, R2 and Rf are measured from micrographs. Three
contributions to the surface decrease are estimated theoretically and shown in the same table: (a) The outer monolayer area decrease given by the enzymatic conversion
to ceramide of the outer SM. Data represent the area reduction by a 20% of the SM concentration in the outer monolayer according to the mean molecular areas of
ceramide and SM obtained in monolayers at 30 mN/m from [37]. This contribution is mitigated by the rapid redistribution of created ceramide. (b) The total area
reduction given by the condensing effect of the new synthesized ceramides on the fluid lipid matrix. Data represent the variation in the mean molecular area of the
overall membrane depending on proportion of synthesized ceramide, according to [42]. Because of heterogeneity of acyl chains in brain SM, the area decreased used
here was an average value from C16:0 ceramide and C24:1 ceramide described in [42]. (c) The SM asymmetry defined as the area difference between both monolayers
over the total lipid area, after the total redistribution of the newly formed ceramide. The shape change is characterised by an experimental area reduction on the order of
10% (last column), and is independent of SM content in the initial lipid composition.
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vesicle suspension containing Lyso-PC produced an average
decrease in volume of 23±12% (for 8 independent vesicles,
the high standard deviation value takes into account 2 vesicles
which presented volume decrease below 7%) after a few
minutes (Figs. 5a and b). This phenomenon was accompanied
by the formation of small lipid vesicles and/or filaments inside
the GUVs. The stabilising effect of lyso-PC can also be
inferred from the observation that vesicles with 10% of SM,
when treated with SMase, showed the presence of ceramide-
enriched domains (Fig. 5c), indicating that in situ enzymati-
cally produced ceramide reached a concentration high enough
to allow domains formation before any appreciable irreversible
membrane destabilisation occurred.
3.5. Direct observation of nanoscale defects in supported lipids
bilayers with AFM
Supported bilayers containing EPC:EPE:SM:Chol (1:1:1:1
mol ratio) were prepared for AFM observation. These bilayers
always exhibited two types of domains differing in height byFig. 5. Membrane stabilisation by the presence of lyso-PC in lipid composition a
(1.2:1:0.4:1:0.4 mol) vesicle after incubation with SMase. (a) GUV before addition
volume and invaginated small vesicles and/or filaments can be observed. (c) Rich-ce
the top of a vesicle (here a different vesicle from (a) and (b) and 13 min after Smas0.6 nm. The thicker domains corresponded to liquid ordered (lo)
domains, whereas the thinner ones corresponded to liquid
disordered (ld) domains [27]. Heterogeneity in lipid vesicle
adhesion on the mica surface originated the diversity in relative
ratio and connectivity of the two types of domains observed in
different regions on the mica. Addition of SMase to the aqueous
solution induced three different surface rearrangements that
were apparent to a different extent depending on the ratio of lo/ld
present at the surface analyzed: lo domain reduction, appear-
ance of higher domains corresponding to ceramide rich areas,
and the formation of “holes”. Regions presenting a discontin-
uous lo phases as depicted in Fig. 6 showed a clear decrease in lo
areas during the first minutes of enzymatic exposure, as
reported before [27]. Figs. 6a and b show this shrinkage in
size of lo domains. The second type of enzymatic induced
rearrangement observed is shown in Fig. 6c. New patches
appear that differ in height, shape and position from the original
lo regions observed before enzymatic treatment. The height
difference of these newly appeared patches was now 1 nm (Fig.
6c), with respect to the ld phase, is compatible with ceramide
domains constituted after accumulation of enzymatic generatednd visualisation of rich-ceramide domains in an EPC:EPE:SM:Chol:Lyso-PC
of SMase, (b) The same vesicle 7 min after SMase addition. Both decrease of
ramide domains (visualised as dark “channels”) were observed when focusing at
e addition). Scale bars: 10 μm.
Fig. 6. Domain redistribution in supported lipid bilayers containing lo domains (PC:SM:PE:Chol 1:1:1:1) after addition of SMase. Time after injection: (a) 19 min; (b)
60 min; (c) 75 min. lo phase area is decreased from (a) to (b) by SM to ceramide conversion. Finally, in (c), lo phase disappears and the new thicker ceramide patches
appear. The height profiles (indicated with a black bar on AFM images) show the height difference between the ld–lo phase (0,6 nm) and between ld-ceramide domains
(1 nm). Defects in lipid coating (dashed circle) serve as a reference to indicate that the images represent the time evolution of the same region.
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deformation can be interpreted as being indicative of tension
generated by the enzymatic activity, this tension is evidenced
through the appearance of holes formed in the membrane after
enzymatic treatment in regions where the domain prevalence
was reversed and the lo phase constituted the continuous phase
surrounding discontinues ld phase regions (Fig. 7). The
appearance of small holes on an enzymatic treated surface is
shown in Fig. 7b. Previous reports had also described enzymatic
generated holes [27]. Thicker regions similar to the ones
observed in Fig. 6 can also be seen in Fig. 7c, reinforcing the
interpretation that they correspond to domains formed by the
accumulation of ceramides.
4. Discussion
The work presented here shows that in situ enzymatic
conversion of sphingomyelin into ceramide on only one side
of a lipid vesicle generates a surface tension that in turn can
induce shape changes and membrane rupture. SM to ceramide
conversion reduces the mean molecular area occupied by this
lipid by approximately 20% (measured in monolayers at
30 mN/m) [37]. Since only SM in the outer monolayer was
accessible to SMase injected in the medium, the enzyme
activity generated a surface asymmetry in the bilayer. The area
asymmetry can be relaxed by bending the membrane if
vesicles possess a surface excess. It is well documented that
an area difference as low as 0.1% is sufficient to induce a
couple of forces associated with the difference of lateraltension and can trigger budding or invagination in a deflated
GUV [31,38]. Together with the inverted cone shape of
ceramide molecules, a negative curvature should be induced to
the overall membrane and invaginations must be observed
[25]. On the other hand, the newly synthesized ceramide is
expected to eventually equilibrate between both monolayers
[22]. This effect could partially inhibit the induction of
negative curvature in membranes by ceramide. However the
very slow SM diffusion from the inner to the outer monolayer
should maintain a bilayer asymmetry preventing the vesicle
from reversing to a prolate shape. Our experiments indicated
that a stable membrane invagination was produced by
exogenous SMase treatment in prolate vesicles containing
2% of SM.
SM asymmetry explains why spherical vesicles (i.e. unable to
bend) with as little as 5% of SM, and no visible lipid ordered
domains, became unstable upon SMase addition. In the
hypothetical case where ceramide did not redistribute between
both monolayers, the maximum expected molecular area reduc-
tion from SM to ceramide that could be reached after full SM
hydrolysis in the outer leaflet is about 1% (20% reduction of 5%of
the area, assuming that all lipids contribute equally to the total
area). This estimated area reduction is smaller than a priori
necessary for vesicle rupture (3–5% of total lipid surface, [39]).
However, ceramides formed on the outer monolayer are expected
to redistribute between both monolayers within a few minutes
[22]. The flow of newmolecules towards the inner monolayer can
decrease the area difference between leaflets. However a large
initial asymmetry in our hands can generate transitory defects and/
Fig. 7. Direct observation of nanoscale defects produced by SM to ceramide conversion. Time after injection of Smase: (a) 0 min, (b) 60 min and (c) 65 min. The
scanned region in (a) and (b) is the same as that delimited by a dashed square in (c). Dimensions of the dashed square are 5 μm×5 μm. The nanometre-sized holes that
appear upon enzymatic treatment are pointed out by arrow heads (b). The ceramide rich domains indicated by white arrows are also observables in (c). The profile from
the black bar on AFM images indicating the relative heights of different kinds of domains is shown in (d).
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[40]. In any case the high tension asymmetry provokes instabilities
in the lipid bilayer [41,42].
Another contribution to the surface tension is given by the
condensing effect of new ceramides on the molecular packing of
PC matrix [43]. In the latter case, and because of the ceramide
redistribution, the membrane tension acts in both monolayers
and becomes a symmetric tension. Decreases of ∼1 to ∼22%
on mean molecular areas have been measured depending on
ceramide concentrations (from 5 to 50% mol) and on acyl
chains composition in a DMPC matrix [43]. Apart from, or in
conjunction with the SM asymmetrical distribution, the
condensing effect of the newly formed ceramides should be
an important contribution to the surface tension for high SM
ratios (>15% mol) because of the high heterogeneity of acyl
chains of the brain SM used here.
Recently the group of Ohki showed that SMase incubation of
vesicles containing DOPC, C16–Cer, C16–SM and Cholesterol
transform the liquid-ordered and disordered phases into gel and
liquid phase [28]. No mention was made of the overall apparent
membrane area reduction in their results. Our observations
indicated that the SMase activity produced observable shape
changes that reflect an overall vesicle area decrease. At constant
volume the measured area reduction was ∼10%, (see Fig. 4).
This quantity is larger than the estimated area reduction comingfrom the SM asymmetry and the condensing effect contributions
for vesicles with a small SM content. Therefore, the area
reduction cannot be explained by these two contributions in this
case. In fact, deflated vesicles with domains posses an area
excess. Thus, this measured area reduction of 10% corresponds
to a geometrical accommodation to the volume of the new
decreased surface, and consequently independent of SM content.
The surface tension associated to such high lateral stress is never
reached because the interfacial tension between domains relaxes
the stretched vesicle thereby preventing rupture in a first
moment. Once the spherical shape was reached, vesicles
underwent the formation of ceramide-enriched domains and
ruptured, according to the critical area strains (2–3%) for vesicle
containing high amounts of cholesterol or SM [39]. Vesicles
containing EPE:EPC:SM:chol, and 5% or 10% of both of SM
and lyso-PC did not rupture under SMase treatment. They
decreased in size and were able to accumulate enough ceramide
on their surface to form visible ceramide rich domains. Change
in vesicle volume without apparent rupture suggests the leakage
of the inner content by transient defects as a response to the
tension created by the enzyme activity but healed after enough
inner volume was expelled and reduced vesicle size and
membrane tension. The origin of defects can be diverse. One
hypothesis is the potential of newly formed ceramide molecules
to induce lamellar-inverted hexagonal phase transitions on PE
560 I. López-Montero et al. / Biochimica et Biophysica Acta 1768 (2007) 553–561and cholesterol matrix [9]. This possibility is however unlikely
within the range of temperatures (20 °C) and for the lower
concentrations of initial SM, i.e. 5% mol, present in our
experiments [9]. In addition, the presence of Lyso-PC should
mitigate the ceramide HII-phase induction [23]. Another
hypothesis that we favour is the formation of hydrophilic
transient pores stabilised by the high positive spontaneous
curvature of Lyso-PC. The positive curvature of lyso-PC can
contribute to the membrane stabilisation by reducing the
hydrophobic region in contact with water and by connecting
the two opposing monolayers. These transient pores must be of
nanometres size since they are not visible by optical microscopy.
The latter hypothesis was confirmed by AFM visualisation of
planar lipid domains possessing an average size of several
nanometres (see Fig. 7). Several reasons can explain why we do
not detect transient pores with a longer life-time. First, the
presence of cholesterol increases the line tension of pores and
reduces their lifetimes. Second, the low viscosity of aqueous
solution prevents the visualisation of macroscopic transitory
pores [44].
A direct consequence of transient pore formation is the
transfer of lipids from the inner monolayer to the outer
monolayer along the pores' edges [45]. Furthermore, the surface
mismatch produced by ceramide formation could be rapidly
relaxed by this mechanism. Defect lifetimes of 10− 3 to 10− 1 s
involve a net transbilayer flux of 103–105 lipids trough a defect
with radius of several nanometres [46,47]. This mechanism
could be the way by which SM and ceramide production allow
lipid scrambling, an effect that has been documented in different
biological and reconstituted systems [26,48]. In agreement with
the interpretation that it is the ceramide asymmetric generation
that promotes lipid scrambling [48,49], one could extrapolate
this observation to a biological situation and postulate that
endogenous SMase could be a lipid scramblase.
5. Conclusion
In this article SM to ceramide conversion was produced by
hydrolysis of SM polar head group in a single leaflet. Several
phenomena then contributed to the formation of an area difference
between the two monolayers: (1) the disappearance of SM head
group of the outer monolayer shrinks the outer monolayer area;
(2) the absence of transmembrane distribution of SM between the
two monolayers caused by the very slow SM transmembrane
diffusion does not enable equilibration between the two
monolayers; (3) the symmetrical area decrease coming from the
condensing effect of synthetised and redistributed ceramides.
All these processes fully explain in a quantitative way
membrane bending, transitory pore formation, and/or membrane
collapse observed in experimentswith SMcontainingGUVswhen
incubated with SMase. Pore formation is possibly helped by the
presence of lyso-PC in the lipid composition of the membranes.
The high positive curvature of Lyso-PC, should favour transient
pores, enabling lipids to flip from one monolayer to the other.
These observations by optical microscopy and confirmed in AFM
experiments, are responses of the vesicles that attempt to relax the
surface tension generated by the lipid asymmetry. This processresults in lipid scrambling, thus SM located in the innermonolayer
can become also accessible to SMase.
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